These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 23926208)

  • 1. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
    Varbo A; Benn M; Nordestgaard BG
    Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol as a causal risk factor for ischemic heart disease.
    Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
    J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant cholesterol and ischemic heart disease.
    Varbo A; Nordestgaard BG
    Curr Opin Lipidol; 2014 Aug; 25(4):266-73. PubMed ID: 24977981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
    Varbo A; Freiberg JJ; Nordestgaard BG
    Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.
    Varbo A; Benn M; Smith GD; Timpson NJ; Tybjaerg-Hansen A; Nordestgaard BG
    Circ Res; 2015 Feb; 116(4):665-73. PubMed ID: 25411050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
    Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to letters regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation".
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2014 Jun; 129(24):e656. PubMed ID: 24934470
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Jones et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation".
    Jones SR; Martin SS; Brinton EA
    Circulation; 2014 Jun; 129(24):e655. PubMed ID: 24934469
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Scharnagl et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation".
    Scharnagl H; Kleber ME; März W
    Circulation; 2014 Jun; 129(24):e654. PubMed ID: 24934468
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
    JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
    Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
    J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population: Mendelian randomization study.
    Ooi EM; Afzal S; Nordestgaard BG
    Circ Cardiovasc Genet; 2014 Oct; 7(5):650-8. PubMed ID: 25065375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
    Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
    Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
    Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
    Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
    Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
    Andersen RV; Wittrup HH; Tybjaerg-Hansen A; Steffensen R; Schnohr P; Nordestgaard BG
    J Am Coll Cardiol; 2003 Jun; 41(11):1972-82. PubMed ID: 12798568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
    Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
    J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.